Research on ethical risk governance of medical artificial intelligence based on domestic and foreign policy analysis
10.12026/j.issn.1001-8565.2024.09.07
- VernacularTitle:基于国内外政策分析的医疗人工智能伦理风险治理研究
- Author:
Aiyi ZHANG
1
;
Zhongguang YU
2
Author Information
1. Clinical Pharmacology Research Center， Peking Union Medical College Hospital， Beijing 100005， China
2. Respiratory center， China-Japan Friendship Hospital， Beijing 100029， China
- Publication Type:Journal Article
- Keywords:
medical artificial intelligence;
ethical risk governance;
risk assessment
- From:
Chinese Medical Ethics
2024;37(9):1061-1067
- CountryChina
- Language:Chinese
-
Abstract:
With the rapid development and widespread application of artificial intelligence （AI） technology， it has brought convenience to people’s lives and work， while bringing a series of ethical challenges such as lack of transparency， privacy leakage， limited autonomy in decision-making， and blurred responsibility attribution. By comparing the ethical risk governance of the application of AI in the medical field， this paper systematically analyzed 30 policy regulations issued by 10 countries and international organizations， revealing the consensus and differences in ethical governance of medical AI internationally. The results showed that transparency， fairness and justice， non-harm， privacy protection， freedom and autonomy， responsibility， and people-oriented principles were seven internationally recognized ethical principles， providing important guidance for building a safe， trustworthy， and humane-respecting medical AI ecosystem. In addition， this paper deeply compared the risk assessment methods in the guidelines of China， the United States， and the European Union， as well as found differences in risk types， risk grading， and risk assessment process standards. These differences not only reflect diversities in different cultural， legal backgrounds， and regulatory concepts， but also highlight the necessity of strengthening international cooperation in the context of globalization. Therefore， it is recommended to develop ethical risk governance standards and norms for medical AI that applicable to China’s national conditions. Based on drawing on international experience， proactively carry out risk assessments， reduce ethical challenges， and promote the healthy and rational application of medical AI technology.
